The Association of British Neurologists' myasthenia gravis guidelines

Publisher： John Wiley & Sons Inc

E-ISSN： 1749-6632|1412|1|166-169

ISSN： 0077-8923

Source： ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol.1412, Iss.1, 2018-01, pp. : 166-169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developing treatment guidelines for myasthenia gravis

By  

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 1412, Iss. 1, 2018-01 ,pp. : 95-101

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rationale for the clinical guidelines for myasthenia gravis in Japan

By  

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 1413, Iss. 1, 2018-02 ,pp. : 35-40

John Wiley & Sons Inc

Access to resources Recommend Favorite

A unique subphenotype of myasthenia gravis

By  

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 1412, Iss. 1, 2018-01 ,pp. : 14-20

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serological and experimental studies in different forms of myasthenia gravis

By  

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 1413, Iss. 1, 2018-02 ,pp. : 143-153

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rituximab in myasthenia gravis: a “to be or not to be” inhibitor of T cell function

By  

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 1413, Iss. 1, 2018-02 ,pp. : 41-48

John Wiley & Sons Inc

Access to resources Recommend Favorite